PSY7310 provides the neuroscience foundation every psychologist needs regardless of specialization. Behavior, cognition, emotion, and psychopathology are produced by a brain. Understanding how neural communication works, how brain structures mediate specific psychological functions, how neurotransmitter systems relate to mental health conditions and their pharmacological treatment, and how experience reshapes neural architecture through neuroplasticity connects psychological phenomena to their biological substrate. This course does not reduce psychology to biology; it integrates the biological level of analysis with the psychological and social levels.
Major neurotransmitter systems and their psychological relevance
| Neurotransmitter | Primary Functions | Clinical Relevance |
|---|---|---|
| Serotonin (5-HT) | Mood regulation, sleep, appetite, impulse control | Low serotonin linked to depression, anxiety, OCD; SSRIs increase serotonin availability |
| Dopamine (DA) | Reward, motivation, motor control, executive function | Mesolimbic pathway: addiction and reward; nigrostriatal: Parkinson's; mesocortical: schizophrenia negative symptoms |
| Norepinephrine (NE) | Arousal, attention, stress response, mood | Fight-or-flight activation; ADHD stimulant mechanism; SNRIs target NE for depression |
| GABA | Primary inhibitory neurotransmitter; reduces neural excitability | Low GABA linked to anxiety; benzodiazepines enhance GABA-A activity; alcohol acts on GABA |
| Glutamate | Primary excitatory neurotransmitter; learning, memory (LTP) | NMDA receptor role in learning; glutamate hypothesis of schizophrenia; excitotoxicity in neurodegeneration |
| Acetylcholine (ACh) | Memory, attention, muscle contraction | Cholinergic decline in Alzheimer's; nicotine acts on ACh receptors |
| Endorphins | Pain modulation, pleasure, stress response | Opioid receptor system; runner's high; opioid drugs mimic endorphin effects |
What PSY7310 covers
Neural communication begins at the cellular level: the resting potential, the action potential (all-or-none firing), synaptic transmission (neurotransmitter release, receptor binding, reuptake, enzymatic degradation), and the distinction between excitatory and inhibitory postsynaptic potentials. Understanding this process at a mechanistic level is essential because it explains how psychotropic medications work: SSRIs block the serotonin transporter, preventing reuptake and increasing serotonin availability; benzodiazepines bind to GABA-A receptors and enhance their inhibitory effect; antipsychotics block dopamine D2 receptors. Without understanding the synapse, medication mechanisms are black boxes.
Brain structure and function covers the major anatomical structures and their roles in behavior: the prefrontal cortex (executive function, decision-making, impulse control), the amygdala (fear conditioning, emotional processing), the hippocampus (memory consolidation, spatial navigation), the hypothalamus (homeostatic regulation, HPA axis activation), the basal ganglia (motor control, habit formation, reward processing), and the cerebellum (motor coordination, procedural learning). Understanding structure-function relationships enables psychologists to interpret the neuropsychological consequences of brain injury, understand the neurodevelopmental basis of disorders like ADHD (prefrontal cortex maturation delay) and schizophrenia (prefrontal and temporal lobe abnormalities), and engage meaningfully with neuroimaging research.
The HPA (hypothalamic-pituitary-adrenal) stress axis is the biological mechanism linking stress to health outcomes and psychopathology. Chronic stress produces sustained cortisol elevation that damages hippocampal neurons (impairing memory), suppresses immune function, increases inflammation, and contributes to depression, anxiety, cardiovascular disease, and metabolic syndrome. Understanding the HPA axis connects the biological level to the psychological (stress appraisal, coping) and social (poverty, discrimination, adverse childhood experiences) levels in a genuinely biopsychosocial framework.
Writing about neurotransmitter systems, the HPA axis, or neuroplasticity?
Our psychology writers connect neuroscience to behavior with the mechanistic precision and clinical relevance Capella's doctoral rubric demands.
Key topics you write about in PSY7310
- Neural communication: action potential, synaptic transmission, neurotransmitter lifecycle, excitatory and inhibitory postsynaptic potentials
- Neurotransmitter systems: serotonin, dopamine, norepinephrine, GABA, glutamate, acetylcholine pathways and their behavioral roles
- Brain structure and function: cortical lobes, limbic system, basal ganglia, brainstem structures, lateralization
- The HPA stress axis: cortisol, chronic stress effects, allostatic load, stress and psychopathology connection
- Neuroplasticity: experience-dependent plasticity, critical periods, synaptic pruning, neurogenesis, rehabilitation implications
- Behavioral genetics: heritability, twin studies, adoption studies, gene-environment interaction, epigenetics
- Psychopharmacology: mechanisms of action for antidepressants, antipsychotics, anxiolytics, mood stabilizers, stimulants
- Neuroimaging: fMRI, PET, EEG/ERP methodologies, what they can and cannot tell us about brain function
- Sleep neuroscience: sleep stages, circadian rhythms, sleep and memory consolidation, sleep disorders
- Neuroscience of psychopathology: neural correlates of depression, anxiety, PTSD, schizophrenia, addiction
Common writing assignments
Neurotransmitter system analysis
Students examine a specific neurotransmitter system in depth, covering the synthesis and metabolism of the neurotransmitter, the neural pathways it operates in, its role in normal behavior, its role in psychopathology when dysregulated, and the pharmacological agents that target it. Strong papers connect the neuroscience to observable psychological phenomena rather than stopping at the molecular level.
Biopsychosocial integration paper
Students analyze a specific behavior or disorder (addiction, PTSD, depression, aggression) through a biopsychosocial lens, integrating the biological mechanisms (neural circuits, neurotransmitters, genetics, HPA axis) with the psychological factors (cognition, learning, personality) and social factors (environment, culture, relationships) that interact to produce the phenomenon. The integration must be genuine, showing how the levels interact rather than listing them separately.
Connecting neuroscience to psychology in PSY7310 papers
- Start with the behavior or psychological phenomenon, not the neuroscience. The behavior is what psychologists care about; the neuroscience explains the mechanism.
- Explain the neural mechanism at the appropriate level of detail. Sufficient to understand how it works; not so detailed that it becomes a biology paper without psychological relevance.
- Connect back to clinical or applied implications. How does understanding the dopamine reward pathway change how we understand and treat addiction? How does understanding cortisol's effect on the hippocampus inform trauma-informed practice?
- Acknowledge the limits of biological explanation. Neural correlates are not causal explanations. fMRI activation does not equal the psychological experience. The brain enables behavior; it does not fully explain it.
How GradeEssays helps with PSY7310
GradeEssays supports psychology students with neurotransmitter analyses, brain structure papers, HPA axis analyses, biopsychosocial integration papers, and behavioral neuroscience writing. When you share your topic and Capella's rubric, your writer produces neuroscience writing that connects biological mechanisms to psychological phenomena. All work is original and delivered with time for your review.
Get Help With PSY7310
Neurotransmitter analyses, brain structure papers, HPA axis and stress, neuroplasticity, psychopharmacology, biopsychosocial integration. Neuroscience that connects to behavior.
Place Your Order View All ServicesRelated courses
Frequently asked questions
Neuroplasticity is the brain's ability to reorganize its structure and function in response to experience, learning, injury, or environmental changes. It operates through several mechanisms: synaptic plasticity (strengthening or weakening of existing synaptic connections through long-term potentiation and long-term depression), structural plasticity (growth of new dendritic spines, axonal sprouting), and neurogenesis (formation of new neurons, primarily in the hippocampus). Neuroplasticity matters for psychology because it is the biological mechanism through which psychological intervention produces lasting change. Psychotherapy that reduces anxiety rewires the amygdala-prefrontal cortex circuitry. Cognitive rehabilitation after stroke leverages cortical reorganization. Trauma exposure creates maladaptive neural patterns; trauma therapy creates new patterns. Without neuroplasticity, psychological intervention would have no lasting biological effect. Understanding neuroplasticity also explains critical periods in development, the brain's capacity for recovery after injury, and the neurological basis of learning and memory.
The dopamine hypothesis proposes that schizophrenia symptoms result from dysregulation of dopamine neurotransmission. The original hypothesis (excessive dopamine activity) was supported by two observations: drugs that increase dopamine (amphetamines, L-DOPA) can produce psychotic symptoms in healthy individuals, and all effective antipsychotic medications block dopamine D2 receptors. The revised hypothesis distinguishes between dopamine pathways: excessive dopamine activity in the mesolimbic pathway produces positive symptoms (hallucinations, delusions, disorganized thinking), while deficient dopamine activity in the mesocortical pathway produces negative symptoms (flat affect, social withdrawal, cognitive deficits) and cognitive symptoms. This revision explains why traditional antipsychotics (which block D2 receptors broadly) are effective against positive symptoms but often worsen negative symptoms. Atypical antipsychotics, which have different receptor profiles, show modest improvement in negative symptoms. The glutamate hypothesis has emerged as a complementary model, noting that NMDA receptor hypofunction produces both positive and negative symptoms.
The hypothalamic-pituitary-adrenal (HPA) axis is the body's primary stress response system. When the brain perceives a threat, the hypothalamus releases corticotropin-releasing hormone (CRH), which stimulates the anterior pituitary to release adrenocorticotropic hormone (ACTH), which stimulates the adrenal cortex to release cortisol. Cortisol mobilizes energy, suppresses non-essential functions (immune, digestive, reproductive), and enhances alertness. Under normal conditions, negative feedback loops shut the HPA axis down when the threat passes. Chronic stress disrupts this feedback, producing sustained cortisol elevation that damages the hippocampus (impairing memory consolidation and HPA feedback), suppresses immune function, increases systemic inflammation, and alters prefrontal cortex function (impairing executive control). This chronic dysregulation is linked to depression (HPA hyperactivity is one of the most reliable biological findings in major depression), PTSD (paradoxically, some studies show HPA hypoactivity), anxiety disorders, and physical health consequences including cardiovascular disease, metabolic syndrome, and accelerated aging.
Selective serotonin reuptake inhibitors (SSRIs) work by blocking the serotonin transporter (SERT) on the presynaptic neuron. Normally, after serotonin is released into the synaptic cleft and binds to postsynaptic receptors, the serotonin transporter reabsorbs (reuptakes) the remaining serotonin back into the presynaptic neuron, terminating its signal. SSRIs block this transporter, leaving more serotonin in the synaptic cleft for a longer duration, increasing serotonergic neurotransmission. The therapeutic delay (2-4 weeks before clinical improvement) suggests that the immediate increase in synaptic serotonin is not the direct mechanism of antidepressant effect. Instead, the sustained increase in serotonin availability triggers downstream adaptive changes: postsynaptic receptor desensitization, changes in gene expression, increased brain-derived neurotrophic factor (BDNF) production, and possibly neurogenesis in the hippocampus. These slower neuroplastic changes, rather than the immediate neurotransmitter effect, are likely the mechanism through which SSRIs produce lasting improvement in depressive symptoms.